Market Neuron Logo
⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

DEEPAKNTR - Investment Analysis: Buy Signal or Bull Trap?

Last Updated Time : 20 Dec 25, 07:05 am

Back to Investment List

Investment Rating: 2.4

Stock Code DEEPAKNTR Market Cap 22,729 Cr. Current Price 1,666 ₹ High / Low 2,665 ₹
Stock P/E 107 Book Value 232 ₹ Dividend Yield 0.46 % ROCE 10.1 %
ROE 8.22 % Face Value 2.00 ₹ DMA 50 1,655 ₹ DMA 200 1,883 ₹
Chg in FII Hold -0.47 % Chg in DII Hold 0.09 % PAT Qtr 112 Cr. PAT Prev Qtr 30.3 Cr.
RSI 44.9 MACD -30.0 Volume 2,37,806 Avg Vol 1Wk 1,72,093
Low price 1,513 ₹ High price 2,665 ₹ PEG Ratio -5.42 Debt to equity 0.01
52w Index 13.3 % Qtr Profit Var -21.5 % EPS 15.6 ₹ Industry PE 26.6

📊 Analysis: DEEPAKNTR shows weak fundamentals for long-term compounding. ROE at 8.22% and ROCE at 10.1% are below ideal thresholds. Valuation is extremely stretched with P/E at 107 compared to industry average of 26.6, while PEG ratio (-5.42) highlights poor growth-adjusted valuation. Dividend yield at 0.46% is modest, and debt-to-equity at 0.01 reflects a nearly debt-free balance sheet. EPS at 15.6 ₹ is low relative to market cap. Technicals show RSI at 44.9 (neutral), MACD negative (-30.0), and price below 200 DMA (1,883 ₹), indicating bearish sentiment. Quarterly PAT dropped from 30.3 Cr. to 112 Cr. but overall profit variance (-21.5%) raises sustainability concerns.

💡 Entry Zone: Safer entry would be in the 1,400–1,550 ₹ range, aligning with valuation comfort and support levels. Current price (1,666 ₹) is above fair entry zone, making risk-reward unattractive at present.

📈 Exit Strategy: If already holding, consider tactical exit near 1,850–1,950 ₹ resistance. Long-term holding is not favorable unless ROE improves above 12–15% and earnings growth stabilizes. Suggested holding period: short to medium term (6–18 months) rather than multi-year compounding.

Positive

Limitation

Company Negative News

Company Positive News

Industry

Conclusion

🔎 DEEPAKNTR is not a strong candidate for long-term investment due to weak ROE/ROCE and stretched valuations. Entry should be avoided at current levels; wait for correction near 1,400–1,550 ₹. Existing holders may exit near resistance zones or hold short-term only. Long-term compounding potential is limited unless profitability metrics improve significantly.

Would you like me to extend this into a peer benchmarking overlay comparing DEEPAKNTR against chemical sector peers like Aarti Industries, Atul Ltd, and SRF to highlight relative valuation comfort zones?

Back to Investment List

NIFTY 50 - Today Top Investment Picks Stock Picks

NEXT 50 - Today Top Investment Picks Stock Picks

MIDCAP - Today Top Investment Picks Stock Picks

SMALLCAP - Today Top Investment Picks Stock Picks